10/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

10/2024

Oct 31, 2024, 14:12 | Blog
Shearwood McClelland: National Mentoring Day with Dr. Wendy Woodward
Shearwood McClelland, Director of Spine Oncology at University Hospitals' Department of Radiation Oncology, shared on…
Oct 31, 2024, 14:07 | Insight
All the way from the Clinic and Scientific Publications - ESTRO
ESTRO shared a post on X: “Insights into the scientific writing process from the clinic…
Oct 31, 2024, 14:06 | Blog
Todd Davis: Swissmedic has approved FILSPARI for the treatment of adults with primary IgA nephropathy
Todd Davis, Chief Executive Officer & Director at Ligand Pharmaceuticals, shared on LinkedIn: "We have…
Oct 31, 2024, 14:04 | Insight
Ramy Sedhom: Penn Medicine is hiring an oncology research nurse and a clinical research coordinator
Ramy Sedhom, Assistant Professor of Hematology and Oncology at Perelman School of Medicine, shared on…
Oct 31, 2024, 14:01 | Blog
Tedros Adhanom Ghebreyesus: WHO needs sustainable, flexible, predictable and resilient financing to deliver Health For All
Tedros Adhanom Ghebreyesus shared on LinkedIn: "World Health Organization needs sustainable, flexible, predictable and resilient financing…
Oct 31, 2024, 13:04 | Blog
Megan-Claire Chase: No one goes through cancer unscathed
Megan-Claire Chase, Director of SHARE Cancer Support and Patient Advocate, shared this post on LinkedIn:…
Oct 31, 2024, 12:50 | Insight
Andrea Necchi: Phase I (TEM-GU) study is recruiting patients with metastatic clear cell renal carcinoma
Andrea Necchi, Associate Editor at Journal of Clinical Oncology, posted the following on X: “Happy…
Oct 31, 2024, 12:49 | Blog
Neeraj Agarwal: Why Words Matter in Advanced Prostate Cancer
Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the…
Oct 31, 2024, 12:37 | Blog
Vorasidenib doubled PFS for patients with Grade 2 gliomas with IDH1 or IDH2 mutations - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "In a global phase 3, double-blinded, randomized clinical trial,…
Oct 31, 2024, 12:27 | Blog
Megan-Claire Chase: Ways in which NBCF helps address barriers in health equity
Megan-Claire Chase, Breast Cancer Program Director at Share Cancer Support, shared on LinkedIn: "I got to…
All: 2802 Posts: 51 - 60
Special Coverage